Zion Market Research has published a new report titled "Regenerative Medicines Market by Therapy (Tissue Engineering, Cell Therapy, Immunotherapy, and Gene Therapy), by Material (Synthetic Materials, Biologically Derived Materials, Genetically Engineered Materials, and Others), and by Application (Oncology, Orthopedic and Musculoskeletal Spine, Cardiovascular, Dermatology, Central Nervous System, Diabetes, and Others) - Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024". According to the report, global regenerative medicines market was valued at approximately USD 7.97 billion in 2017 and is expected to generate revenue of around USD 26.30 billion by the end of 2024, growing at a CAGR of around 18.59% between 2017 and 2024.